LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

Search

McKesson Corp

Fermé

SecteurSoins de santé

942.1 -0.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

921

Max

947.56

Chiffres clés

By Trading Economics

Revenu

40M

1.3B

Ventes

3B

106B

P/E

Moyenne du Secteur

27.246

57.833

Rendement du dividende

0.33

Marge bénéficiaire

1.177

Employés

43,000

EBITDA

374M

1.8B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+5.71% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.33%

2.47%

Prochains Résultats

7 mai 2026

Date du Prochain Dividende

1 avr. 2026

Date du Prochain Détachement de Dividende

1 juin 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

11B

116B

Ouverture précédente

942.21

Clôture précédente

942.1

Sentiment de l'Actualité

By Acuity

44%

56%

134 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

McKesson Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 mars 2026, 22:42 UTC

Résultats

Prudential PLC 2025 Adjusted Operating Profit Rises

17 mars 2026, 21:40 UTC

Résultats

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 mars 2026, 23:56 UTC

Market Talk

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 mars 2026, 23:46 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

17 mars 2026, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 mars 2026, 23:42 UTC

Market Talk

RBA's Return to Policy Tightening Will Work -- Market Talk

17 mars 2026, 23:38 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 mars 2026, 23:24 UTC

Market Talk

Global Energy Roundup: Market Talk

17 mars 2026, 23:24 UTC

Market Talk

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 mars 2026, 22:22 UTC

Market Talk

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 mars 2026, 22:20 UTC

Résultats

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 mars 2026, 22:20 UTC

Résultats

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 mars 2026, 22:07 UTC

Résultats

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 mars 2026, 22:05 UTC

Résultats

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 mars 2026, 22:04 UTC

Résultats

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 mars 2026, 22:03 UTC

Résultats

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 mars 2026, 22:01 UTC

Résultats

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 mars 2026, 22:01 UTC

Résultats

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 mars 2026, 22:01 UTC

Résultats

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 mars 2026, 21:26 UTC

Résultats

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 mars 2026, 21:09 UTC

Résultats

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 mars 2026, 21:08 UTC

Résultats

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 mars 2026, 21:08 UTC

Résultats

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mars 2026, 21:07 UTC

Résultats

Couche-Tard 3Q EPS 82c >ATD.T

17 mars 2026, 21:06 UTC

Résultats

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q EPS 82c >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q Net $757.2M >ATD.T

17 mars 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Energy & Utilities Roundup: Market Talk

Comparaison

Variation de prix

McKesson Corp prévision

Objectif de Prix

By TipRanks

5.71% hausse

Prévisions sur 12 Mois

Moyen 997.1 USD  5.71%

Haut 1,107 USD

Bas 885 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

11 ratings

9

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

681.92 / 707.28Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

No Evidence

Long Terme

No Evidence

Sentiment

By Acuity

134 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat